K251355

Substantially Equivalent

X1-FFR

Applicant: Spectrawave, Inc.
Product code: QHA
Advisory panel: Radiology
Date received: 2025-04-30
Decision date: 2025-10-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bedford, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.